Aurora Cannabis Inc.

NasdaqCM:ACB Stock Report

Market Cap: US$258.1m

Aurora Cannabis Future Growth

Future criteria checks 4/6

Aurora Cannabis is forecast to grow earnings and revenue by 129.9% and 10.7% per annum respectively while EPS is expected to grow by 78.3% per annum.

Key information

129.9%

Earnings growth rate

78.3%

EPS growth rate

Pharmaceuticals earnings growth19.7%
Revenue growth rate10.7%
Future return on equityn/a
Analyst coverage

Good

Last updated17 Dec 2024

Recent future growth updates

Recent updates

Aurora Cannabis: Revving Up To Profitability

Aug 08

Aurora launches new cannabis products for adult and medical-use

Oct 17

Aurora Cannabis further strengthens its balance sheet by repurchasing ~US$23M of convertible notes

Oct 07

Aurora Cannabis Q4 2022 Earnings Preview

Sep 19

Aurora Cannabis: Don't Let Your Money Go Up In Smoke

Aug 25

Why Did Aurora Cannabis Stock Crash In May; Can It Recover?

Jun 13

Recent Developments Do Not Change Our Stance On Aurora Cannabis

May 13

Aurora Cannabis: A Train Wreck Desperate For Help

May 05

Aurora Cannabis: The Fallen Pot Giant That Still Can't Find Its Way

Feb 17

Aurora Cannabis Vs. HEXO: Which Is The Better Cannabis Stock?

Dec 17

Tilray Vs. Aurora Cannabis: How To Compare These Cannabis Stocks

Oct 11

Aurora Cannabis: Investors Should Have No Confidence In This Company

Sep 28

Is Aurora Cannabis Stock A Buy Or Sell Before Upcoming Earnings? Buy The U.S. Opportunity

Sep 16

Aurora Cannabis Is A Pass For Now, Although We Are Bullish On The Industry

Jun 05

Aurora Cannabis: Extreme Downside Case Averted

Feb 02

Earnings and Revenue Growth Forecasts

NasdaqCM:ACB - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2027387415372
3/31/2026359513384
3/31/2025329-12-2-66
9/30/2024297-30-61-43N/A
6/30/2024279-30-67-49N/A
3/31/2024270-55-85-69N/A
12/31/2023266-116-91-71N/A
9/30/2023262-153-145-127N/A
6/30/2023248-195-141-127N/A
3/31/2023224-793-163-142N/A
12/31/2022212-1,748-181-157N/A
9/30/2022210-1,757-152-118N/A
6/30/2022221-1,718-142-110N/A
3/31/2022226-1,233-98-64N/A
12/31/2021231-381-122-82N/A
9/30/2021238-607-165-124N/A
6/30/2021245-692-264-211N/A
3/31/2021257-2,387-357-284N/A
12/31/2020275-2,359-430-285N/A
9/30/2020263-3,342-614-357N/A
6/30/2020269-3,231-691-342N/A
3/31/2020299-1,405-778-293N/A
12/31/2019291-1,430-787-289N/A
9/30/2019290-385-667-218N/A
6/30/2019246-294-606-192N/A
3/31/2019168-211-519-233N/A
12/31/2018119-72-439-206N/A
9/30/201877174-334-146N/A
6/30/20185572N/A-82N/A
3/31/201842-13N/A-35N/A
12/31/2017317N/A-16N/A
9/30/201723-4N/A-15N/A
6/30/201718-13N/A-13N/A
3/31/201713-16N/A-17N/A
12/31/20168-13N/A-11N/A
9/30/20165-10N/A-9N/A
6/30/20161-6N/A-7N/A
3/31/201600N/A-5N/A
12/31/2015N/A-3N/A-3N/A
9/30/2015N/A-10N/A-3N/A
6/30/2015N/A-10N/A-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ACB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: ACB is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ACB is expected to become profitable in the next 3 years.

Revenue vs Market: ACB's revenue (10.7% per year) is forecast to grow faster than the US market (9% per year).

High Growth Revenue: ACB's revenue (10.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if ACB's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 04:22
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aurora Cannabis Inc. is covered by 20 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Frederico Yokota Choucair GomesATB Capital Markets
Tamy ChenBMO Capital Markets Equity Research
Heather BalskyBofA Global Research